Back
Fate Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
FATE
Sponsored
Escape the market madness with 7 stocks to buy and hold
Get the complete list FREE for a limited time.
Sell
34
FATE
Fate Therapeutics
Last Price:
2.81
Seasonality Move:
31.52%
7 Day Trial
ALL ACCESS PASS
$
7
Nvidia's Secret Partner... This Is The New AI Chip Powerhouse
Details Here!Fate Therapeutics Price Quote
$2.81
-0.22 (-7.26%)
(Updated: October 24, 2024 at 6:30 PM ET)
Fate Therapeutics Key Stats
Sell
34
Fate Therapeutics (FATE)
is a Sell
Day range:
$3.00 - $3.21
52-week range:
$1.63 - $8.83
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
26.92
P/B ratio:
0.92%
Volume:
1.1M
Avg. volume:
1.1M
1-year change:
68.33%
Market cap:
$363.3M
Revenue:
$63.5M
EPS:
$-1.71
How Much Does Fate Therapeutics Make?
-
How Much Are Fate Therapeutics's Sales Annually?
FATE Revenues are $63.5M -
How Much Profit Does Fate Therapeutics's Make A Year?
FATE net income is -$160.9M
Is Fate Therapeutics Growing As A Company?
-
What Is Fate Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 6.26% -
What Is Fate Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Fate Therapeutics Stock Price Performance
-
Did Fate Therapeutics Stock Go Up Last Month?
Fate Therapeutics share price went down by -16.76% last month -
Did FATE's Share Price Rise Over The Last Year?
FATE share price rose by 68.33% over the past 1 year
What Is Fate Therapeutics 52-Week High & Low?
-
What Is Fate Therapeutics’s 52-Week High Share Price?
Fate Therapeutics has traded as high as $8.83 over the past 52 weeks -
What Is Fate Therapeutics’s 52-Week Low Share Price?
Fate Therapeutics has traded as low as $1.63 over the past 52 weeks
Fate Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Fate Therapeutics?
-
How Much Debt Does Fate Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Fate Therapeutics Have?
Cash and short term investments quarterly total is $304.9M -
What Is Fate Therapeutics’s Book Value Per Share?
Book value per share is 3.49
Is Fate Therapeutics Cash Flow Positive?
-
What Is FATE Cash Flow From Operations?
Cash flow from operations (TTM) is -$140.6M -
What Is Fate Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $96.6M -
What Is Fate Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $34.1M
Fate Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
FATE return on invested capital is -43.24% -
What Is Fate Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -32.14% -
What Is FATE Return On Equity?
ROE is a measure of profitability and is -43.24%
Fate Therapeutics Earnings Date & Stock Price
-
What Is Fate Therapeutics's Stock Price Today?
A single share of FATE can be purchased today for 3.03 -
What Is Fate Therapeutics’s Stock Symbol?
Fate Therapeutics trades on the nasdaq under the ticker symbol: FATE -
When Is Fate Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Fate Therapeutics is scheduled on November 8, 2024 -
When Is FATE's next ex-dividend date?
Fate Therapeutics's next ex-dividend date is April 30, 2020 -
How To Buy Fate Therapeutics Stock?
You can buy Fate Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Fate Therapeutics Competitors
-
Who Are Fate Therapeutics's Competitors?
Below is a list of companies who compete with Fate Therapeutics or are related in some way:
Fate Therapeutics Dividend Yield
-
What Is FATE Dividend Yield?
Fate Therapeutics’s dividend yield currently is 0% -
What Is Fate Therapeutics’s Payout Ratio?
Fate Therapeutics’s payout ratio is 0% -
When Did Fate Therapeutics Last Pay A Dividend?
The latest dividend pay date is October 24, 2024 -
What Is Fate Therapeutics’s Dividend Per Share?
Fate Therapeutics pays a dividend of $0.00 per share
Fate Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 27.23% |
Revenue: | 625.83% | 337.45% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 11 |
Sell Recommendations: | 0 |
Price Target: | 6.46 |
Upside from Last Price: | 113.15% |